• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MultiPlan Acquires Leading Healthcare Data and Analytics Firm Benefits Science LLC

    5/9/23 7:00:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary
    Get the next $MPLN alert in real time by email

    Ushers in a new era of the company, accelerates launch of new Data & Decision Science service line with a world-class data & analytics platform and team at BST

    MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, today announced that it has acquired Benefits Science LLC ("Benefits Science Technologies" or "BST"), a next generation data and advanced analytics company that combines modern data science, including machine learning and artificial intelligence ("AI"), with deep expertise in healthcare to deliver solutions that reduce the cost of care and improve health outcomes.

    This acquisition will combine the capabilities of two leaders in the healthcare arena to provide cutting edge, differentiated solutions to customers across a full spectrum of healthcare channels and markets through our new Data & Decision Science service line. The acquisition unites MultiPlan's 40+ years of experience and institutional knowledge in healthcare cost management and payment accuracy and its rich and expansive claims data with BST's cutting-edge analytics and AI capabilities. Furthermore, the acquisition of BST strengthens MultiPlan's foothold in large and fast-growing adjacent markets by unlocking the value of its significant and expanding claims flows for in-network commercial, Medicare Advantage and other government programs, property and casualty, and supplemental insurance markets.

    BST's Software as a Service ("SaaS") platform adds best-in-class data and analytics capabilities that connect with over 160 carriers, plan administrators, and other healthcare stakeholders. The platform ingests, validates, and stores massive amounts of data with exceptional accuracy, and applies advanced descriptive, predictive, and prescriptive analytics to help employers and their advisors, commercial health plans and government health plans to optimize decision-making and financial and clinical performance.

    BST was founded in 2012 by a group of MIT-trained experts in data science, including Dimitris Bertsimas, Ph.D., who is recognized as an early pioneer in healthcare analytics and who serves as the company's chief data scientist. Dr. Bertsimas will continue with BST post-closing. Today, BST's machine learning algorithms and AI software help about 75,000 employers to predict future risk and manage health plan decisions.

    Key products BST brings to MultiPlan's new Data & Decision Science service line include:

    • Price Transparency – a modern self-service software platform jointly developed with MultiPlan that provides prescriptive analytics and applications to help customers benchmark network performance, optimize network design, and improve competitive positioning. In less than a second, the solution can query over 500 billion records of machine-readable payor and provider pricing data now required by regulation to be made public. The solution will aggregate this vast contracted rate information and enrich it with MultiPlan's extensive proprietary demographic and affiliate data on 1.3 million contracted providers, pricing technology, and deep clinical billing expertise.
    • BenInsights – a modern software platform for employers and their consultants that quickly and accurately aggregates a plan's data and provides highly flexible financial and clinical reporting and decision tools through a self-service software platform. BenInsights also integrates predictive risk modeling and prescriptive analytics and value-added services, such as benefit plan design and optimization.
    • Risk Analytics & Insights – solutions that complement existing actuarial-based modeling by applying interpretable risk models, risk scoring, and prescriptive analytics for commercial and government health plans. Among other services, risk scoring can seamlessly attach to MultiPlan's prepayment claims flows to help identify emergent risks by individual, group, or condition, and prescribe financial and clinical program enhancements across a plan sponsor's organization.
    • Other Market Solutions – a group of software solutions for supplemental insurance carriers and stop loss carriers, including digital claiming, digital underwriting, and targeted selling tools, that help improve plan performance and competitive positioning.

    "This is a tremendous milestone for MultiPlan. This transaction brings together two leading healthcare technology companies that share a vision of solving healthcare's most pressing problems," said Dale White, CEO and President of MultiPlan. "BST's platform, products and intellectual capital, combined with MultiPlan's customer reach and expansive claims data will deliver rich, actionable data rapidly and prescriptively to health plans and employers seeking to improve care, avoid cost, and achieve greater return on investment. I am very excited about the significant growth opportunities our new Data & Decision Science service line will generate for MultiPlan."

    "We are excited to join with MultiPlan to drive deployment of data-driven solutions more broadly to the industry," added Stephen Sofoul, CEO and President of BST. "BST was founded on the belief that data science advancements will increasingly influence decisions made by employers and other risk bearers. Over the past decade, we've developed a product portfolio driven by advanced analytics including machine learning algorithms for predicting future risk and artificial intelligence software for managing health plan decisions. Combined now with MultiPlan, we are even better equipped to help our customers improve the quality of care at a lower overall cost."

    Under the transaction agreement, MultiPlan will pay a consideration of $160 million, comprised of $140.8 million in cash and 21.6 million shares of MultiPlan common stock to acquire BST. Additionally, MultiPlan will establish a long-term incentive and retention program pursuant to which BST's management team is eligible to receive target payments of $66 million over three to five years, subject to ongoing service to MultiPlan and to adjustments based on performance relative to annual recurring revenue targets.

    For the full year 2023 on a standalone basis, BST is projected to generate revenues of approximately $16 million with breakeven profitability. MultiPlan expects the acquired company to contribute over $100 million of incremental annual revenues within the next several years and to approach corporate-level profit margins at scale.

    Advisors

    BofA Securities, Inc. served as financial advisor and Kirkland & Ellis LLP and Simpson Thacher & Bartlett LLP served as legal counsel to MultiPlan for this transaction. Truist Securities acted as the exclusive financial advisor and Latham & Watkins LLP served as legal advisory to BST.

    About MultiPlan

    MultiPlan is committed to delivering affordability, efficiency and fairness to the US healthcare system by helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets customers' needs and customizes innovative solutions that combine its payment and revenue integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government and property and casualty markets. For more information, visit multiplan.com.

    About BST

    Founded in 2012 in Boston, MA by MIT-trained data scientists, BST combines world-class technical knowledge and practical experience to harness powerful data-driven insights for the healthcare industry. Their experts have extensive industry experience and unique backgrounds at the intersection of analytics, healthcare and software development. BST is unique in the market in its ability to describe what has occurred, predict what's likely to occur, and prescribe the next best action designed to mitigate future risks. For more information, visit www.benefitsscience.com

    Forward Looking Statements

    This press release contains forward-looking statements. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "forecasts," "intends," "plans," "may," "will" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, including MultiPlan's expectations and beliefs with respect to the acquisition of BST and the impact of such acquisition on MultiPlan. The forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 and speak only as of the date they are made. Any forward-looking statements that we make herein are not guarantees of future performance and actual results may differ materially from those in such forward-looking statements as a result of various factors. Factors that may impact such forward-looking statements also include the factors discussed under "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022; and other factors beyond our control. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company's periodic and other filings are accessible on the SEC's website at www.sec.gov. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230509005328/en/

    Get the next $MPLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MPLN

    DatePrice TargetRatingAnalyst
    6/26/2024$2.00Neutral
    Piper Sandler
    12/13/2022$3.00 → $2.00Buy → Neutral
    Citigroup
    7/12/2022$6.50Neutral
    Goldman
    12/20/2021$9.00 → $7.00Buy
    Citigroup
    11/11/2021$7.00 → $6.00Equal-Weight
    Barclays
    10/4/2021$9.00Buy
    Citigroup
    8/20/2021$9.00Buy
    Tigress Financial
    More analyst ratings

    $MPLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks

    Latest agreement expands access to the PHCS and MultiPlan Networks ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE:CTEV), previously MultiPlan, Inc. (NYSE:MPLN), a technology and data insights company focused on making healthcare more affordable, transparent, and fair for all. As part of the agreement, ClearNote Health's Avantect® Pancreatic Cancer Test will now be available to health plan members accessing Claritev's national PHCS and MultiPlan Networks. While early detection has vastly improved survival rates for many types of cancer, pancreatic cancer is often diagnos

    3/12/25 8:03:00 AM ET
    $CTEV
    $MPLN
    Real Estate
    Business Services
    Consumer Discretionary

    Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

    Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

    2/25/25 6:00:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design

    Claritev's Award-Winning Analytics Solution, BenInsights®, is Powered by Oracle Cloud and Now Available in the Oracle Cloud Marketplace Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and an Oracle partner, announced today its analytics solution, BenInsights®, has achieved Integrated with Oracle Cloud Expertise and is now available in the Oracle Cloud Marketplace, offering added value to Oracle Cloud customers. The BenInsights platform enables visibility into benefit plan performance and compliance responsibilities for employers of

    2/21/25 8:00:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    $MPLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Information Officer Kim Michael bought $249,588 worth of shares (40,000 units at $6.24), increasing direct ownership by 3% to 1,312,772 units (SEC Form 4)

    4 - MultiPlan Corp (0001793229) (Issuer)

    11/19/24 4:35:27 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    SVP, Corp. Affairs/Strategy Mintz William B. bought $104,359 worth of shares (278,165 units at $0.38), increasing direct ownership by 14% to 2,206,736 units (SEC Form 4)

    4 - MultiPlan Corp (0001793229) (Issuer)

    8/8/24 4:30:55 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    Pres., Chief Executive Officer Dalton Travis bought $185,000 worth of shares (500,000 units at $0.37), increasing direct ownership by 11% to 5,004,504 units (SEC Form 4)

    4 - MultiPlan Corp (0001793229) (Issuer)

    8/7/24 6:05:14 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    $MPLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by SVP, Chief Information Officer Kim Michael

    4/A - MultiPlan Corp (0001793229) (Issuer)

    12/13/24 4:28:52 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    SVP, Chief Information Officer Kim Michael bought $249,588 worth of shares (40,000 units at $6.24), increasing direct ownership by 3% to 1,312,772 units (SEC Form 4)

    4 - MultiPlan Corp (0001793229) (Issuer)

    11/19/24 4:35:27 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    SVP, Chief Growth Officer Misencik Tiffani was granted 95,328 shares (SEC Form 4)

    4 - MultiPlan Corp (0001793229) (Issuer)

    10/16/24 5:01:01 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    $MPLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on MultiPlan with a new price target

    Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00

    6/26/24 7:57:01 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    MultiPlan downgraded by Citigroup with a new price target

    Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously

    12/13/22 9:12:38 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    Goldman initiated coverage on MultiPlan with a new price target

    Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50

    7/12/22 7:32:35 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    $MPLN
    Leadership Updates

    Live Leadership Updates

    View All

    MultiPlan Appoints Tiffani Misencik to Drive Strategic Growth

    Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an

    10/22/24 2:00:00 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    MultiPlan Makes Fortune's Best Workplaces in Health Care List for Second Year in a Row

    MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer

    9/12/24 8:30:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    MultiPlan Announces CFO Transition

    MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

    8/1/24 6:00:00 AM ET
    $DOOR
    $MPLN
    $ORCL
    Forest Products
    Basic Materials
    Business Services
    Consumer Discretionary

    $MPLN
    Financials

    Live finance-specific insights

    View All

    Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

    Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

    2/25/25 6:00:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

    MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, announced today that it will release its fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique pin. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadsho

    1/28/25 8:30:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    MultiPlan Reports Third Quarter 2024 Results and Updates 2024 Guidance

    – Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,

    11/5/24 6:00:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    $MPLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

    SC 13G/A - MultiPlan Corp (0001793229) (Subject)

    11/12/24 4:00:27 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

    SC 13G/A - MultiPlan Corp (0001793229) (Subject)

    11/4/24 3:13:44 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

    SC 13G/A - MultiPlan Corp (0001793229) (Subject)

    11/4/24 1:43:06 PM ET
    $MPLN
    Business Services
    Consumer Discretionary

    $MPLN
    SEC Filings

    View All

    SEC Form 10-K filed by MultiPlan Corporation

    10-K - Claritev Corp (0001793229) (Filer)

    2/26/25 7:50:06 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    MultiPlan Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Claritev Corp (0001793229) (Filer)

    2/25/25 6:21:17 AM ET
    $MPLN
    Business Services
    Consumer Discretionary

    MultiPlan Corporation filed SEC Form 8-K: Other Events

    8-K - Claritev Corp (0001793229) (Filer)

    2/24/25 8:02:11 AM ET
    $MPLN
    Business Services
    Consumer Discretionary